Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial.

Song IH, Hermann K, Haibel H, Althoff CE, Listing J, Burmester G, Krause A, Bohl-Bühler M, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2011 Apr;70(4):590-6. doi: 10.1136/ard.2010.139667. Erratum in: Ann Rheum Dis. 2011 Jul;70(7):1350. Althoff, Ce [corrected to Althoff, C E].

PMID:
21372193
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.

Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Weiss A, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2011 Jul;70(7):1257-63. doi: 10.1136/ard.2010.147033. Epub 2011 May 8.

PMID:
21551507
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.

Rudwaleit M, Baraliakos X, Listing J, Brandt J, Sieper J, Braun J.

Ann Rheum Dis. 2005 Sep;64(9):1305-10. Epub 2005 Mar 18. Erratum in: Ann Rheum Dis. 2005 Nov;64(11):1668.

PMID:
15778243
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.

Song IH, Althoff CE, Haibel H, Hermann KG, Poddubnyy D, Listing J, Weiß A, Djacenko S, Burmester GR, Bohl-Bühler M, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2012 Jul;71(7):1212-5. doi: 10.1136/annrheumdis-2011-201010. Epub 2012 Mar 22.

PMID:
22440819
[PubMed - indexed for MEDLINE]
5.

A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial.

Dougados M, Combe B, Braun J, Landewé R, Sibilia J, Cantagrel A, Feydy A, van der Heijde D, Leblanc V, Logeart I.

Ann Rheum Dis. 2010 Aug;69(8):1430-5. doi: 10.1136/ard.2009.121533. Epub 2010 May 28.

PMID:
20511606
[PubMed - indexed for MEDLINE]
6.

Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial.

Dougados M, van der Heijde D, Sieper J, Braun J, Maksymowych WP, Citera G, Miceli-Richard C, Wei JC, Pedersen R, Bonin R, Rahman MU, Logeart I, Wajdula J, Koenig AS, Vlahos B, Alvarez D, Bukowski JF.

Arthritis Rheumatol. 2014 Aug;66(8):2091-102. doi: 10.1002/art.38721.

PMID:
24891317
[PubMed - indexed for MEDLINE]
7.

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.

Song IH, Weiß A, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Lange E, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2013 Jun;72(6):823-5. doi: 10.1136/annrheumdis-2012-202389. Epub 2012 Nov 21.

PMID:
23172749
[PubMed - indexed for MEDLINE]
8.

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison.

Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Wajdula J, Fatenejad S; Etanercept European Investigators Network (Etanercept Study 309 Investigators).

Ann Rheum Dis. 2006 Oct;65(10):1357-62. Epub 2006 Apr 10.

PMID:
16606651
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.

Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M.

Ann Rheum Dis. 2010 Jun;69(6):1065-71. doi: 10.1136/ard.2009.111187. Epub 2009 Sep 9.

PMID:
19740906
[PubMed - indexed for MEDLINE]
10.

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).

Sieper J, van der Heijde D, Dougados M, Mease PJ, Maksymowych WP, Brown MA, Arora V, Pangan AL.

Ann Rheum Dis. 2013 Jun;72(6):815-22. doi: 10.1136/annrheumdis-2012-201766. Epub 2012 Jul 7.

PMID:
22772328
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial.

Braun J, van der Horst-Bruinsma IE, Huang F, Burgos-Vargas R, Vlahos B, Koenig AS, Freundlich B.

Arthritis Rheum. 2011 Jun;63(6):1543-51. doi: 10.1002/art.30223.

PMID:
21630245
[PubMed - indexed for MEDLINE]
Free Article
12.

May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study.

Migliore A, Massafra U, Bizzi E, Argento G, Diamanti AP, Germano V, Tormenta S, Arduini F, Iannessi F, Granatas M, Laganà B.

Eur Rev Med Pharmacol Sci. 2012 Mar;16(3):363-9.

PMID:
22530354
[PubMed - indexed for MEDLINE]
13.

Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study.

Marzo-Ortega H, McGonagle D, O'Connor P, Emery P.

Arthritis Rheum. 2001 Sep;44(9):2112-7.

PMID:
11592375
[PubMed - indexed for MEDLINE]
Free Article
14.

MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.

Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J.

Ann Rheum Dis. 2008 Sep;67(9):1276-81. Epub 2007 Nov 15.

PMID:
18006539
[PubMed - indexed for MEDLINE]
15.

Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.

Althoff CE, Sieper J, Song IH, Haibel H, Weiß A, Diekhoff T, Rudwaleit M, Freundlich B, Hamm B, Hermann KG.

Ann Rheum Dis. 2013 Jun;72(6):967-73. doi: 10.1136/annrheumdis-2012-201545. Epub 2012 Jun 26.

PMID:
22736088
[PubMed - indexed for MEDLINE]
16.
17.

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.

Combe B, Codreanu C, Fiocco U, Gaubitz M, Geusens PP, Kvien TK, Pavelka K, Sambrook PN, Smolen JS, Khandker R, Singh A, Wajdula J, Fatenejad S; Etanercept European Investigators Network.

Ann Rheum Dis. 2009 Jul;68(7):1146-52. doi: 10.1136/ard.2007.087106. Epub 2008 Sep 15.

PMID:
18794178
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammation.

Døhn UM, Skjødt H, Hetland ML, Vestergaard A, Møller JM, Knudsen LS, Ejbjerg BJ, Thomsen HS, Ostergaard M.

Clin Rheumatol. 2007 Nov;26(11):1857-61. Epub 2007 Feb 27.

PMID:
17332974
[PubMed - indexed for MEDLINE]
19.

Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis.

van der Heijde D, Sieper J, Maksymowych WP, Brown MA, Lambert RG, Rathmann SS, Pangan AL.

Arthritis Rheumatol. 2014 Mar;66(3):667-73. doi: 10.1002/art.38283.

PMID:
24574227
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.

Smolen JS, Nash P, Durez P, Hall S, Ilivanova E, Irazoque-Palazuelos F, Miranda P, Park MC, Pavelka K, Pedersen R, Szumski A, Hammond C, Koenig AS, Vlahos B.

Lancet. 2013 Mar 16;381(9870):918-29. doi: 10.1016/S0140-6736(12)61811-X. Epub 2013 Jan 17.

PMID:
23332236
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk